menu
The ophthalmic drugs contract manufacturing market is estimated to be worth USD 1.7 billion in 2030
It features in-depth analyses, highlighting the capabilities of a diverse set of CMOs and CDMOs.

Outsourcinghas become a popular trend among ophthalmic drug developers, allowing them toleverage the expertise / larger production capacities of CMOs / CDMOs andachieve significant cost and time related advantages

 

RootsAnalysis is pleased toannounce the publication of its recent study, titled, “OphthalmicDrugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredientsand Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels, Injections,Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030.

 

The report features an extensive study of thecontract services market for ophthalmicproducts and solutions. It features in-depth analyses, highlightingthe capabilities of a diverse set of CMOs and CDMOs. Amongst other elements,the report includes:

§  A detailed review ofthe ophthalmic drugs contract manufacturing market landscape, featuring a listof over 240 CMOs and analysis based on a number of relevant parameters.

§  A competitivenessanalysis of prominent contract manufacturers, featuring insightful pictorialsummaries and representations.

§  Elaborate profiles ofkey players that offer a diverse range of capabilities for the contract development,manufacturing and packaging of ophthalmicdrug products.

§  A detailed clinicaltrial analysis of completed, ongoing and planned studies of various ophthalmicdrug products.

§  An estimate of theoverall, annual capacity for manufacturing ophthalmic APIs and drug FDFs basedon data reported by industry stakeholders in the public domain.

§  An informed estimateof the annual clinical and commercial demand for ophthalmic APIs and drug FDFs.

§  A discussion onaffiliated trends, key drivers and challenges, under a comprehensive SWOTframework, including a Harvey ball analysis highlighting the relative effect ofeach SWOT parameter on the overall industry.

§  A survey analysisfeaturing inputs solicited from various experts who are directly / indirectlyinvolved in providing contract manufacturing services to ophthalmic drugdevelopers.

§  A discussion on theemerging trends and potential market drivers, which are likely to impact theevolution of the market in the coming years.

§  A detailed list ofover 55 ophthalmicmedical device contract manufacturers, along with information on a numberof relevant parameters.

 

A detailedmarket forecast, featuring analysis of the current and projected futureopportunity across key market segments (listed below)

§  Typeof product

§  OphthalmicAPI

§  Ophthalmicdrug FDF

 

To request a sample copy / brochure, please visit this - https://www.rootsanalysis.com/reports/294/request-sample.html

 

§ Type of FDF manufactured

§  Solid

§  Semi-solid

§  Liquid/ suspension

 

§  Typeof primary packaging

§  Ampoule/ vial 

§  Glass/ plastic bottle

§  Ointmenttube

§  Blisterpacking

§  Otherforms

 

§  Scaleof manufacturing

§  Clinical

§  Commercial

 

§  Companysize

§  Small

§  Mid-sized

§  Large

§  Verylarge

 

§  Targetdisease indication

§  Age-relatedmacular degeneration

§  Dryeye

§  Glaucoma

§  Otherdisease segments

 

§  Keygeographical regions

§  NorthAmerica (US, Canada and Mexico)

§  Europe(UK, Germany, France, Spain, Italy and rest of Europe)

§  Asia-Pacific(India, China, Japan, Australia and rest of Asia-Pacific)

§  Restof the world

 

Key companies coveredin the report

§  Akorn

§  Akums

§  BalPharma

§  Catalent

§  CaymanChemical

§  EntodPharmaceuticals

§ Farmigea

§  GlenmarkPharmaceuticals

§  IndianaOphthalmics

§ Lomapharm

§  Medichem

§  Pillar5Pharma

§  Recipharm

§  Salvat

§  SterlingPharmaceutical Services

§  SunwaysIndia

 

For more informationplease click on the following link:

https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html

 

Other Recent Offerings

1.   ChinaBiopharmaceutical Contract Manufacturing Market, 2020-2030

2.   PharmaceuticalContinuous Manufacturing Market, 2020-2030

3.  PeptideTherapeutics: Contract API Manufacturing Market, 2020-2030

 

About Roots Analysis

Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

 

Contact Information

RootsAnalysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis